Efficacy and safety of anakinra for the treatment of rheumatoid arthritis: an update of the Oregon Drug  Effectiveness Review Project
Kylie Thaler1, Divya V Chandiramani2, Richard A Hansen2, Gerald Gartlehner11Department for Evidence-based Medicine and Clinical Epidemiology, Danube University Krems, Krems, Austria; 2UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, NC, USAObjec...
Guardado en:
Autores principales: | Kylie Thaler, Divya V Chandiramani, Richard A Hansen, et al |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2009
|
Materias: | |
Acceso en línea: | https://doaj.org/article/811a2bc9f0484d3abe7e374918ad85a6 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Hepatotoxicity of tocilizumab and anakinra in rheumatoid arthritis: management decisions
por: Mahamid M, et al.
Publicado: (2011) -
Safety of etanercept in elderly subjects with rheumatoid arthritis
por: Alfredomaria Lurati, et al.
Publicado: (2009) -
Update on the use of rituximab for intractable rheumatoid arthritis
por: R John Looney
Publicado: (2009) -
An Economic Comparison of Treatment Strategies with Anakinra in Systemic Juvenile Idiopathic Arthritis (sJIA)
por: Bullement A, et al.
Publicado: (2021) -
Efficacy, safety, and tolerability of abatacept in the management of rheumatoid arthritis
por: Joseph R Lutt
Publicado: (2009)